NovoSeven recombinant Factor VIIa from Novo-Nordisk is now officially a blockbuster. It sold $250M (1450 DKK) in 4Q06, +11% year-over-year in local currencies. The U.S. and Canada comprised half of worldwide sales. (Source: Today’s NVO webcast)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.